Abstract
THE neuronal nicotinic α7 (nAChR) and 5-hydroxytryptamine (5HT3) receptors1–3 are ligand-gated ion channels with a homologous topological organization and have activation and desensitization reactions in common. Yet these homo-oligomeric receptors differ in the pharmacology of their binding sites for agonists and competitive antagonists3,4, and in their sensitivity to Ca2+ ions. The α7 channel is highly permeable to Ca2+ ions 5,6 and external Ca2+ ions potentiate, in an allosteric manner, the permeability response to acetylcholine, as shown for other neuronal nAChRs7,8. The 5HT3 channel, in contrast, is not permeable to Ca2+ ions, but blocked by them3,9. To assign these properties to delimited domains of the primary structure, we constructed several recombinant chimaeric α7–5HT3 receptors. We report here that one of the constructs expresses a functional receptor that contains the serotonergic channel still blocked by Ca2+ ions, but is activated by nicotinic ligands and potentiated by external Ca2+ ions.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Couturier, S. et al. Neuron 5, 845–856 (1990).
Schoepfer, R., Conroy, W. G., Whiting, P., Gore, M. & Lindstrom, J. Neuron 5, 35–48 (1990).
Maricq, A. V., Peterson, A. S., Brake, A. J., Myers, R. M. & Julius, D. Science 254, 432–437 (1991).
Bertrand, D., Bertrand, S. & Ballivet, M. Neurosci. Lett. 146, 87–90 (1992).
Séguéla, P., Wadiche, J., Dineley-Miller, K., Dani, J. A. & Patrick, J. W. J. Neurosci. 13, 596–604 (1993).
Bertrand, D., Galzi, J. L., Devillers-Thiéry, A., Bertrand, S. & Changeux, J. P. Proc. natn. Acad. Sci. U.S.A. 90, 6971–6975 (1993).
Mulle, C., Léna, C. & Changeux, J. P. Neuron 8, 937–945 (1992).
Vernino, S., Amador, M., Luetje, C. W., Patrick, J. & Dani, J. A. Neuron 8, 127–134 (1992).
Peters, J. A., Hales, T. G. & Lambert, J. J. Eur. J. Pharm. 151, 491–495 (1988).
Dennis, M. et al. Biochemistry 27, 2346–2357 (1988).
Galzi, J. L. et al. J. biol. Chem. 265, 10430–10437 (1990).
Kuhse, J., Schmieden, V. & Betz, H. Neuron 5, 867–873 (1990).
Vandenberg, R. J., French, C. R., Barry, P. H., Shine, J. & Schofield, P. R. Proc. natn. Acad. Sci. U.S.A. 89, 1765–1769 (1992).
Sigel, E., Baur, R., Kellenberger, S. & Malherbe, P. EMBO J. 11, 2017–2023 (1992).
Karlin, A. Curr. Opin. Neurobiol. 3, 299–309 (1993).
Claudio, T., Ballivet, M., Patrick, J. & Heinemann, S. Proc. natn. Acad. Sci. U.S.A. 80, 1111–1115 (1983).
Devillers-Thiéry, A., Giraudat, J., Bentaboulet, M. & Changeux, J. P. Proc. natn. Acad. Sci. U.S.A. 80, 2067–2071 (1983).
Noda, M. et al. Nature 301, 251–255 (1983).
Giraudat, J., Dennis, M., Heidmann, T., Chang, J. Y. & Changeux, J. P. Proc. natn. Acad. Sci. U.S.A. 83, 2719–2723 (1986).
Hucho, F., Oberthür, W. & Lottspeich, F. FEBS Lett. 205, 137–142 (1986).
Imoto, K. et al. Nature 324, 670–674 (1986).
Mayne, K. M., Yoshii, K., Yu, L., Lester, H. A. & Davidson, N. Molec. Brain Res. 2, 191–197 (1987).
Yu, X. M. & Hall, Z. W. Nature 352, 64–67 (1991).
Sumikawa, K. Molec. Brain Res. 13, 349–353 (1992).
Bradley, P. B. et al. Neuropharmacology 25, 563–576 (1986).
Higashi, H. & Nishi, S. J. Physiol., Lond. 323, 543–567 (1982).
Yakel, J. L., Lagrutta, A., Adelaman, J. P. & North, R. A. Proc. natn. Acad. Sci. U.S.A. 90, 5030–5033 (1993).
Yang, J., Mathie, A. & Hille, B. J. Physiol., Lond. 448, 237–256 (1992).
Miledi, R. & Parker, I. J. Physiol. 357, 173–183 (1984).
Galzi, J. L. et al. Nature 359, 500–505 (1992).
Yang, J. J. Gen. Pbysiol. 96, 1177–1198 (1990).
Popot, J. L. & Engelman, D. Biochemistry 29, 4031–4037 (1990).
Higuchi, R., Krummel, B. & Saiki, R. K. Nucleic Acids Res. 16, 7351–7367 (1989).
Swick, A. G., Janicot, M., Cheneval-Kastelic, T., McLenithan, J. C. & Lane, M. D. Proc. natn. Acad. Sci. U.S.A. 89, 1812–1816 (1992).
Bertrand, D., Cooper, E., Valera, S., Rungger, D. & Ballivet, M. Electrophysiology of Neuronal Nicotinic Acetylcholine Receptors Expressed in Xenopus Oocytes Following Nuclear Injection of Genes or cDNA 1-174-193 (Academic, San Diego, 1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eiselé, JL., Bertrand, S., Galzi, JL. et al. Chimaeric nicotinic–serotonergic receptor combines distinct ligand binding and channel specificities. Nature 366, 479–483 (1993). https://doi.org/10.1038/366479a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/366479a0
This article is cited by
-
An original potentiating mechanism revealed by the cryo-EM structures of the human α7 nicotinic receptor in complex with nanobodies
Nature Communications (2023)
-
Global versus local mechanisms of temperature sensing in ion channels
Pflügers Archiv - European Journal of Physiology (2018)
-
Trapping of ivermectin by a pentameric ligand-gated ion channel upon open-to-closed isomerization
Scientific Reports (2017)
-
Selective Manipulation of Neural Circuits
Neurotherapeutics (2016)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.